xtr004
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 15, 2022 (NCT05885841)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07187895 | Phase 2 | Dec 19, 2024 | Sinotau Pharmaceutical Group |
| NCT05885841 | Phase 2 | Feb 15, 2022 | Sinotau Pharmaceutical Group |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sinotau Pharmaceutical Group | Academic/Hospital | 2 | 2 | 1 | 2022 |
1 organizations
Page 1 / 1